Mitochondrial targeted drug delivery combined with manganese catalyzed Fenton reaction for the treatment of breast cancer

ROS in cancer therapy: the bright side of the moon

(2020) Bruno Perillo et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Biointerface anisotropy modulates migration of breast cancer cell

(2020) Jing Dai et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Altered mitochondria functionality defines a metastatic cell state in lung cancer and creates an exploitable vulnerability

(2020) Chen-Hua Chuang et al.   CANCER RESEARCH

Do TUNEL and Other Apoptosis Assays Detect Cell Death in Preclinical Studies?

(2020) Razmik Mirzayans et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Zebrafish as a preclinical in vivo screening model for nanomedicines

(2019) Sandro Sieber et al.   ADVANCED DRUG DELIVERY REVIEWS

Terminal Deoxynucleotidyl Transferase-Catalyzed Preparation of pH-Responsive DNA Nanocarriers for Tumor-Targeted Drug Delivery and Therapy

(2019) Guo-Ying Sun et al.   ACS Applied Materials & Interfaces

Sequential Intercellular Delivery Nanosystem for Enhancing ROS-Induced Antitumor Therapy

(2019) Binghua Wang et al.   NANO LETTERS

Cytochrome c: An extreme multifunctional protein with a key role in cell fate

(2019) Roberto Santucci et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

SOX2 in development and cancer biology

(2019) Daniel Novak et al.   SEMINARS IN CANCER BIOLOGY

Pregnancy and Breast Cancer: Pathways to Understand Risk and Prevention

(2019) Priscila F. Slepicka et al.   TRENDS IN MOLECULAR MEDICINE

Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis

(2019) Sijia Liu et al.   CLINICAL CANCER RESEARCH

Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers

(2018) Gang Zhou et al.   ADVANCED DRUG DELIVERY REVIEWS

Post-translational modification of OCT4 in breast cancer tumorigenesis

(2018) Yunhee Cho et al.   CELL DEATH AND DIFFERENTIATION

Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity

(2018) Deli Hong et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The multifaceted contributions of mitochondria to cellular metabolism

(2018) Jessica B. Spinelli et al.   NATURE CELL BIOLOGY

Enhanced Permeability and Retention-like Extravasation of Nanoparticles from the Vasculature into Tuberculosis Granulomas in Zebrafish and Mouse Models

(2018) Federico Fenaroli et al.   ACS Nano

Chemodynamic Therapy: Tumour Microenvironment-Mediated Fenton and Fenton-like Reaction

(2018) Zhongmin Tang et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Mitochondria as a therapeutic target for common pathologies

(2018) Michael P. Murphy et al.   NATURE REVIEWS DRUG DISCOVERY

Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy

(2018) Caina Xu et al.   JOURNAL OF CONTROLLED RELEASE

Sildenafil citrate improves the delivery and anticancer activity of doxorubicin formulations in a mouse model of breast cancer

(2017) Khaled Greish et al.   JOURNAL OF DRUG TARGETING

Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer

(2017) Jiahui Xu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Upholding a role for EMT in breast cancer metastasis

(2017) Xin Ye et al.   NATURE

Synthesis of Iron Nanometallic Glasses and Their Application in Cancer Therapy by a Localized Fenton Reaction

(2016) Chen Zhang et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Integrated self-assembling drug delivery system possessing dual responsive and active targeting for orthotopic ovarian cancer theranostics

(2016) Chun-Jui Lin et al.   BIOMATERIALS

NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism

(2016) Chia-Lin Chen et al.   Cell Metabolism

Zebrafish as a model for leukemia and other hematopoietic disorders

(2015) Parisa Rasighaemi et al.   Journal of Hematology & Oncology

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

(2015) Lucia Del Mastro et al.   LANCET

Mitochondrial Delivery of Doxorubicin via Triphenylphosphine Modification for Overcoming Drug Resistance in MDA-MB-435/DOX Cells

(2014) Min Han et al.   MOLECULAR PHARMACEUTICS

Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor

(2013) Qi Yin et al.   ADVANCED DRUG DELIVERY REVIEWS

The zebrafish reference genome sequence and its relationship to the human genome

(2013) Kerstin Howe et al.   NATURE

Influence of tumour micro-environment heterogeneity on therapeutic response

(2013) Melissa R. Junttila et al.   NATURE

Mitochondria: In Sickness and in Health

(2012) Jodi Nunnari et al.   CELL

Androgen Receptor Signaling Regulates Cell Growth and Vulnerability to Doxorubicin in Bladder Cancer

(2012) Masaki Shiota et al.   JOURNAL OF UROLOGY

A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study

(2010) M. Hunault-Berger et al.   HAEMATOLOGICA

Generation of clonal zebrafish lines and transplantable hepatic tumors

(2010) Igor Mizgirev et al.   Nature Protocols

Cytochrome c: functions beyond respiration

(2008) Yong-Ling P. Ow et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY